Telomerase: Not just for the elongation of telomeres

BioEssays

Volumn 28, Issue 2, 2006, Pages 109-112

  Calado, Rodrigo T ^a   Chen, Jichun ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE RNA COMPONENT; UNCLASSIFIED DRUG;

AGE; AGING; CARCINOGENESIS; CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; ENZYME ACTIVITY; ENZYME INDUCTION; EPIDERMIS CELL; HAIR GROWTH; HEMATOPOIESIS; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; RNA TRANSLATION; SENESCENCE; STEM CELL MOBILIZATION; TELOMERE;

ANIMALS; BLOOD CELLS; HUMANS; NEOPLASMS; STEM CELLS; TELOMERASE; TELOMERE;

EID: 33644511376     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.20365     Document Type: Review

References (28)

1. Flores I, Cayuela ML, Blasco MA. 2005. Effects of telomerase and telomere length on epidermal stem cell behavior. Science 309:1253-1256.
2. Sarin KY, Cheung P, Gilison D, Lee E, Tennen RI, et al. 2005. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436:1048-1052.
3. Greider CW, Blackburn EH. 1989. A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 337:331-337.
4. Greider CW. 1990. Telomeres, telomerase and senescence. Bioessays 12:363-369.
5. Greider CW, Blackburn EH. 1985. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43:405-413.
6. Lee HW, Blasco MA, Gottlieb GJ, Horner JW2, Greider CW, et al. 1998, Essential role of mouse telomerase in highly proliferative organs. Nature 392:569-574.
7. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, et al. 1999. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96:701-712.
8. Rudolph KL, Chang S, Millard M, Schreiber-Agus N, DePinho RA. 2000. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 287:1253-1258.
9. Wong KK, Chang S, Weiler SR, Ganesan S, Chaudhuri J, et al. 2000. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet 26:85-88.
10. Morrison SJ, Prowse KR, Ho P, Weissman IL. 1996. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5:207-216.
11. Chen J. 2004. Senescence and functional failure of hematopoietic stem cells. Exp Hematol 32:1025-1032.
12. Wang JC, Warner JK, Erdmann N, Lansdorp PM, Harrington L, et al. 2005. Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells. Proc Natl Acad Sci USA 2005 Sep 19, 102:14398-14403.
13. Akimov SS, Ramezani A, Hawley TS, Hawley RG. 2005. Bypass of Senescence, Immortalization and Transformation of Human Hematopoietic Progenitor Cells. Stem Cells 23:1423-1433.
14. Armstrong L, Saretzki G, Peters H, Wappler I, Evans J, et al. 2005. Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. Stem Cells 23:516-529.
15. Ball SE, Gibson FM, Rizzo S, Tooze JA, Marsh JCW, Gordon-Smith EC. 1998. Progressive telomere shortening in aplastic anemia. Blood 91:3582-3592.
16. Brummendorf TH, Rufer N, Holyoake TL, Maciejewski J, Barnett MJ, et al. 2001. Telomere length dynamics in normal individuals and in patients with hematopoietic stem cell-associated disorders. Ann NY Acad Sci 938:293-303.
17. Gurkan E, Tanriverdi K, Baslamisli F. 2005. Telomerase activity in myelodysplastic syndromes. Leuk Res 29:1131-1139.
18. Dokal I, Vulliamy T. 2003. Dyskeratosis congenita: its link to telomerase and aplastic anaemia. Blood Rev 17:217-225.
19. Yamaguchi H, Baerlocher GM, Lansdorp PM, Chanock SJ, Nunez O, et al. 2003. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 102:916-918.
20. Ly H, Calado RT, Allard P, Baerlocher GM, Lansdorp PM, et al. 2005. Functional characterization of telomerase RNA variants found in patients with hematological disorders. Blood 105:2332-2339.
21. Yamaguchi H, Calado RT, Ly H, Kajigaya S, Baerlocher GM, et al. 2005. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Engl J Med 352:1413-1424.
22. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, et al. 2000. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406:641-645.
23. Rudolph KL, Millard M, Bosenberg MW, DePinho RA. 2001. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 28:155-159.
24. Dalerba P, Guiducci C, Poliani PL, Cifola I, Parenza M, et al. 2005. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells. Cancer Res 65:2321-2329.
25. Shammas MA, Koley H, Batchu RB, Bertheau RC, Protopopov A, et al. 2005. Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett's adenocarcinoma cells: mechanism and therapeutic potential. Mol Cancer 4:1-14.
26. Li S, Rosenberg JE, Donjacour AA, Botchkina IL, Hom YK, et al. 2004. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res 64:4833-4840.
27. Atkinson SP, Hoare SF, Glasspool RM, Keith WN. 2005. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters. Cancer Res 65:7585-7590.
28. Kumakura S, Tsutsui TW, Yagisawa J, Barrett JC, Tsutsui T. 2005. Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells. Cancer Res 65:2778-2786.